(2023)
Benefit of postoperative regional nodal irradiation in patients receiving preoperative systemic therapy with docetaxel/carboplatin/trastuzumab/pertuzumab for HER2-positive breast cancer.
BREAST.
72,
(2023)
Incidence of and Influencing Factors for Arm Lymphedema After Salvage Treatment for an Isolated Locoregional Recurrence of Breast Cancer.
JOURNAL OF BREAST CANCER.
26,
6
(2023)
A Retrospective Exploratory Analysis for Serum Extracellular Vesicles Reveals APRIL (TNFSF13), CXCL13, and VEGF-A as Prognostic Biomarkers for Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES.
24,
21
(2023)
The Impact of HER2-Low Expression on Oncologic Outcomes in Hormone Receptor-Positive Breast Cancer.
CANCERS.
15,
22
(2023)
The Role of Post-Mastectomy Radiotherapy in T1-2N1 Breast Cancer Patients: Propensity Score Matched Analysis.
CANCERS.
15,
22
(2023)
Risk factors of breast cancer recurrence in pathologic complete response achieved by patients following neoadjuvant chemotherapy: a single-center retrospective study.
FRONTIERS IN ONCOLOGY.
13,
(2023)
Analysis of Prognoses according to Breast MRI Results in Patients with Axillary Lymph Node Metastases from an Unknown Primary Origin.
YONSEI MEDICAL JOURNAL.
64,
10
(2023)
Comprehensive Clinical Characterization of Decade-Long Survivors of Metastatic Breast Cancer.
CANCERS.
15,
19
(2023)
Oncologic efficacy of gonadotropin-releasing hormone agonist in hormone receptor-positive very young breast cancer patients treated with neoadjuvant chemotherapy.
WORLD JOURNAL OF CLINICAL CASES.
11,
27
(2023)
Prediction Model for Postoperative Quality of Life Among Breast Cancer Survivors Along the Survivorship Trajectory From Pretreatment to 5 Years: Machine Learning-Based Analysis.
JMIR PUBLIC HEALTH AND SURVEILLANCE.
9,
1
(2023)
Pretreatment endocrine symptoms and recurrence-free survival among young premenopausal patients with breast cancer: a prospective cohort study.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY.
15,
(2023)
Genomic characteristics of triple negative apocrine carcinoma: a comparison to triple negative breast cancer.
EXPERIMENTAL AND MOLECULAR MEDICINE.
55,
7
(2023)
Progesterone Receptor Expression Level Predicts Prognosis of Estrogen Receptor-Positive/HER2-Negative Young Breast Cancer: A Single-Center Prospective Cohort Study.
CANCERS.
15,
13
(2023)
Trends of axillary surgery in breast cancer patients with axillary lymph node metastasis: a comprehensive single-center retrospective study.
ANNALS OF SURGICAL TREATMENT AND RESEARCH.
105,
1
(2023)
Diagnostic Value of FDG PET/CT in Surveillance after Curative Resection of Breast Cancer.
CANCERS.
15,
9
(2023)
Interrupting Endocrine Therapy to Attempt Pregnancy after Breast Cancer.
NEW ENGLAND JOURNAL OF MEDICINE.
388,
18
(2023)
Survival advantage of locoregional and systemic therapy in oligometastatic breast cancer: an international retrospective cohort study (OLIGO-BC1).
BREAST CANCER.
30,
3
(2023)
Integrative modeling of tumor genomes and epigenomes for enhanced cancer diagnosis by cell-free DNA.
NATURE COMMUNICATIONS.
14,
1
(2023)
Effectiveness of Self-Assessment, TAilored Information, and Lifestyle Management for Cancer Patients' Returning to Work (START): A Multi-center, Randomized Controlled Trial.
CANCER RESEARCH AND TREATMENT.
55,
2
(2023)
Epidemiology of Second Non-breast Primary Cancers among Survivors of Breast Cancer: A Korean Population-Based Study by the SMARTSHIP Group.
CANCER RESEARCH AND TREATMENT.
55,
2
단행본
(2013)
근거중심의 암생존자 관리.
국립암센터.
공동
(2011)
Handbook of Surgery.
군자출판사.
공동
특허/프로그램
유방 조직에서 유래된 줄기 세포, 이의 제조방법 및 이로부터 분화된 세포.
10-0868316.
20081105.
대한민국
학술회의논문
(2023)
[Breast 3]: Optimal Surgery for Special Populations.
대한외과학회 추계학술대회.
대한민국
(2023)
MZ 유방암학회.
한국유방암학회 추계학술대회.
대한민국
(2023)
Let’s give them chances: from the viewpoint of the Global Breast Cancer Conference and the Korean Breast Cancer Society.
JBCS annual meeting.
일본
(2023)
Future of Breast Cancer Medicine in Asia.
JBCS annual meeting.
일본
(2023)
axillary managements for breast cancer patients.
2023 KACS spring symposium.
대한민국
(2023)
Global Mindset of a Breast Cancer Surgeon.
GBCC 2023.
대한민국
(2023)
Management of Hereditary Breast Cancer - Global Perspectives of Surgical Oncologists.
GBCC 2023.
대한민국
(2023)
Symposium 1: Clinical Implications of the Intrinsic Molecular Subtypes and NGS Panel of Solid Tumors.
SISSO 2023.
대한민국
(2022)
How I do it.
2022 제6회 삼성서울병원 외과 심포지엄.
대한민국
(2022)
Special considerations for young breast cancer patients from a surgeon's viewpoint.
AOCR 2022 & KCR 2022.
대한민국
(2022)
Controversial issues of pregnancy in young breast cancer patients.
제 1회 서울아산병원 유방암 심포지엄.
대한민국
(2022)
Emerging issues in the management of HR+/HER2-early breast cancer.
일본유방암학회.
일본
(2021)
Current issues with neoadjuvant chemotherapy and surgery in breast cancer.
2ND AACR-KCA Joint Conference on Precision Medicine in Solid Tumorsin conjunction with the 24th KCA Fall Symposium.
대한민국
(2021)
What Is Optimal Surgical Width and Margin for Breast Conserving Surgery after Neoadjuvant Chemotherapy?.
ACKSS 2021.
대한민국
(2021)
Issue about how to adapt the update modern treatment for asian patients.
2021 Taipei International Breast Cancer Symposium.
대만
(2021)
New horizon genetic test and cancer prevention.
The 29th annual Meeting of the Japanese Breast Cancer Society.
일본
(2021)
'Meet the Expert' session.
The 29th annual Meeting of the Japanese Breast Cancer Society.
일본
(2021)
Response Guided Surgery for Breast and/or Axilla after Neoadjuvant Chemotherapy.
CACAIMS.
중국
(2020)
Response Guided Surgery for Breast and Axilla after Neoadjuvant Chemotherapy.
ACKSS 2020.
대한민국
(2020)
Breast surgery for HER2+ BC patients after neoadjuvant chemotherapy based on pCR or non-.
한국유방암학회 2020 온라인(LIVE) 추계학술대회.
대한민국
